Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Instagram Outage Disrupts Thousands of U.S. Users 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
NEW YORK, Aug. 08, 2017 -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors who purchased Pingtan Marine Enterprise Ltd.(“Pingtan” or the “Company”) (NASDAQCM:PME) securities between August 8, 2016 through May 10, 2017, inclusive (the “Class Period”).
Investors who have incurred losses in Pingtan Marine Enterprise Ltd. are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you have purchased shares of Pingtan Marine Enterprise Ltd. and would like to assist with the litigation process as a lead plaintiff, you may, no later than August 22, 2017, request that the Court appoint you lead plaintiff of the proposed class.
According to the filed Complaint, throughout the Class Period, Pingtan made false and/or misleading statements and/or failed to disclose that:
- Pingtan is banned from Indonesia;
- Pingtan has used investor capital to finance illegal activity; and
- as a result, Pingtan’s public statements were materially false and misleading at all relevant times.
On May 10, 2017, research firm, Aurelius Value, published a report alleging that the Company was banned from Indonesia and that the Company used investor capital to finance illegal activity, such as fraud, poaching and human trafficking.
On this news, shares of Pingtan fell $1.16 per share, or over 28%, to close at $2.95 per share on May 10, 2017.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
Contact: Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq. Gregory Stone, Director of Case and Financial Analysis Email: [email protected], [email protected] or [email protected] Tel: (800) 575-0735 or (212) 545-4774
